CompaniesCanbex Therapeutics

Canbex Therapeutics

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

160

By Phase

PHASE2: 1

By Status

COMPLETED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
Today
NCT02542787
Hover over trial bars to see details

Recent Trials

NCT02542787Lead Sponsor
Study of VSN16R for the Treatment of Spasticity in Multiple Sclerosis
PHASE2Completed
160 participants
Started: Aug 31, 2015 · Completed: Oct 31, 2017